Career history of Nicholas Adams
Former positions of Nicholas Adams
| Companies | Position | Start | End |
|---|---|---|---|
| RENEURON GROUP PLC | Corporate Officer/Principal | 2019-07-11 | 2020-07-31 |
| REDX PHARMA PLC | Corporate Officer/Principal | 2015-11-04 | 2018-09-30 |
| Antisoma Research Ltd. | Corporate Officer/Principal | 1999-06-30 | 2011-02-28 |
| WEIFA ASA | Corporate Officer/Principal | 2011-06-30 | - |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2009-09-10 | - |
Training of Nicholas Adams
| University of Hertfordshire | Undergraduate Degree |
| The University of Law Ltd. | Graduate Degree |
Statistics
International
| United Kingdom | 7 |
| Norway | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RENEURON GROUP PLC | Health Technology |
| REDX PHARMA PLC | Health Technology |
| Private companies | 3 |
|---|---|
| Antisoma Research Ltd. | |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Nicholas Adams
- Experience
